News
Patients with IBD have a higher risk for interstitial lung disease than the general population, with the risk being more ...
Simple exercise equipment works as well as high-tech gym programs for older adults with lung disease
A new study offers encouraging news for older adults with chronic respiratory conditions who may struggle to access traditional gym-based rehabilitation programs. Researchers found that pulmonary ...
In its second-quarter earnings release, the company said that in July and August 2025 it analyzed interim data from the ...
Consistently tracking KL-6 levels may help predict acute exacerbations in IPF and other types of fibrotic ILDs, a study ...
Large cohort study finds interstitial lung disease independently increases lung cancer risk across all major subtypes, even ...
Net loss for the three months ended June 30, 2025, was $41.6 million or $0.49 per basic and diluted share, compared to a net loss of $28.7 million, or $0.38 per basic and diluted share, for the three ...
Continued approval for this indication is contingent upon verification and description of clinical benefit in a confirmatory trial.
Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...
After positive trial results for TX45, Tectonic Therapeutic is planning a Phase 2 study to test its effects on blood flow in ...
Phase III data show Hernexeos can elicit a confirmed objective response rate of 48% in patients with HER2-mutated NSCLC who had previously been treated with a directed antibody-drug conjugate.
Continued approval of zongertinib may be contingent upon verification of clinical benefit in a confirmatory trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback